Stock Markets June 17, 2026 11:28 AM

Sarepta Options Activity Surges to 5,295 Contracts as Calls Dominate

Mid-morning volume led by July 17, 2026 $20 calls; shares jump 9.6% and volatility climbs

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
SRPT

Options trading in Sarepta Therapeutics (SRPT) accelerated sharply to 5,295 contracts at 10:11 a.m. New York time on Wednesday. Calls accounted for the vast majority of activity, while the company's shares rose 9.6% to $17.30 and short-term volatility metrics moved higher on the session's flow and repricing.

Sarepta Options Activity Surges to 5,295 Contracts as Calls Dominate
SRPT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Options volume in Sarepta rose to 5,295 contracts by 10:11 a.m. New York time, with calls representing 5,201 contracts and puts 94 contracts.
  • The July 17, 2026 $20 call was the most traded series at 4,387 contracts, with open interest reported at 671 contracts as of Tuesday.
  • Sarepta shares climbed 9.6% to $17.30 while three-month implied volatility and the three-month 90/110 skew both increased.

Trading in options tied to Sarepta Therapeutics Inc. (NASDAQ:SRPT) rose to 5,295 contracts at 10:11 a.m. New York time on Wednesday, according to exchange data compiled by Bloomberg.

The intraday flow was overwhelmingly call-heavy. Call volume reached 5,201 contracts while put volume totaled 94 contracts. The put total represented the largest single-session put volume recorded since March 6, 2025.

The most actively traded individual series was the July 17, 2026 $20 call, which accounted for 4,387 contracts. Open interest in that strike stood at 671 contracts as of Tuesday.

Equities trading reflected the options activity. Sarepta Therapeutics shares advanced 9.6%, trading at $17.30 on the session.

Volatility gauges moved higher alongside the surge in options turnover. The three-month implied volatility increased by 7.91 percentage points to 74.94%. In addition, the three-month 90/110 skew widened, rising 1.36 percentage points to 1.32 percentage points.

Below is a concise recap of the session's key data:

  • Aggregate options volume: 5,295 contracts (10:11 a.m. New York time, Wednesday)
  • Call volume: 5,201 contracts
  • Put volume: 94 contracts - highest single-session put volume since March 6, 2025
  • Most traded series: July 17, 2026 $20 call - 4,387 contracts; open interest 671 contracts as of Tuesday
  • Share price change: +9.6% to $17.30
  • Three-month volatility: up 7.91 percentage points to 74.94%
  • Three-month 90/110 skew: up 1.36 percentage points to 1.32 percentage points

The data points above reflect exchange-reported volumes, open interest reported as of Tuesday for the highlighted strike, and quoted equity prices at the noted intraday time. Where the article records a highest put volume since a specific date, that observation is based on the same exchange data compilation.


This briefing presents session-level options and equity metrics for Sarepta Therapeutics without interpretation beyond the reported figures and timestamps.

Risks

  • Put volume totaled 94 contracts, the highest single-session put volume since March 6, 2025, indicating increased observed demand for downside or hedging exposure in the options market.
  • Short-term implied volatility rose to 74.94%, reflecting greater expected price fluctuation in the near term as implied by options prices.

More from Stock Markets

Aramco Lines Up Additional Asset Sales, Including Stake in Sulphur Business, to Raise Tens of Billions Jun 17, 2026 Qatar's Stake in VW Complicates Osnabrueck Sale Talks with Israeli Defence Firm Jun 17, 2026 Italy's Antitrust Authority Launches Probe Into Apple Over iCloud Interoperability Jun 17, 2026 OVHcloud Moves to Build Frontier AI Models, Aiming to Be Europe’s Second Major LLM Player Jun 17, 2026 ASML Flags Supply Risks as It Backs Musk’s Terafab Project Jun 17, 2026